NEUROCRINE BIOSCIENC

NBIX
Delayed Quote. Delayed  - 08/07 04:00:00 pm
115.11USD -0.78%
Upcoming events on NEUROCRINE BIOSCIENCES, INC.
10/28/20 Q3 2020 Earnings Release (Projected)
02/16/21 FY 2020 Earnings Release (Projected)
05/06/21 Q1 2021 Earnings Release (Projected)
08/04/21 Interim 2021 Earnings Release (Projected)

Past events on NEUROCRINE BIOSCIENCES, INC.
08/06/20 | 12:00pmWilliam Blair Biotech Focus Conference
08/03/20 | 04:30pmInterim 2020 Earnings Call
08/03/20Interim 2020 Earnings Release
06/22/20 | 05:00pmBank of America Merrill Lynch Securities Napa Biopharma Conference

Upcoming sector events for NEUROCRINE BIOSCIENCES, INC.

- No events available -


Past sector events for NEUROCRINE BIOSCIENCES, INC.

- No events available -


Annual results
Previous yearNext Year
Annual results20192020 (e)
Sales
M $
Released
Forecast
Spread
788
776
1,5%

1 137
Operating income
(EBITDA)
M $
Released
Forecast
Spread
79,7
114
-30%

316
Operating profit
(EBIT)
M $
Released
Forecast
Spread
72,3
105
-31%

297
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
46,5
87,9
-47%

229
Net income
M $
Released
Forecast
Spread
37,0
78,4
-53%

214
EPS
$
Released
Forecast
Spread
0,39
0,82
-52%

2,17
Announcement Date02/04/2020


Quarterly / Semiannualy publications
Previous periodNext period
Quarterly results2020 Q22020 Q3 (e)
Sales
M $
Released
Forecast
Spread
302
262
16%

289
Operating income
(EBITDA)
M $
Released
Forecast
Spread
83,7
55,1
52%


Operating profit
(EBIT)
M $
Released
Forecast
Spread
76,6
78,6
-2,5%

24,9
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
83,2
72,1
15%

13,8
Net income
M $
Released
Forecast
Spread
79,6
64,0
24%

11,4
EPS
$
Released
Forecast
Spread
0,81
0,66
23%

0,11
Announcement Date08/03/2020

Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise